Vimarsana
Biggest News Aggregation in the World

Page 2 - Project Warp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Warp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Warp Today - Breaking & Trending Today

Close to 'Finish Line,' Novavax Enters Phase 3 Trials for COVID-19 Vaccine - Vimarsana News

Close to 'Finish Line,' Novavax Enters Phase 3 Trials for COVID-19 Vaccine

Close to ‘Finish Line,’ Novavax Enters Phase 3 Trials for COVID-19 Vaccine Novavax, which is headquartered in Gaithersburg and has facilities in Rockville, announced it has moved into Phase 3 of its efficacy trial for its COVID-19 vaccine. Prevent-19 is designed to determine the efficacy, safety and immunogenicity of its vaccine. It expects to enroll up to 30,000 volunteers throughout the United States and Mexico, of which two thirds of the participants will receive the active vaccine, according to the company’s news release. Novavax is participating in the federal government’s Projec...

Editorial: With COVID vaccines, hope for brighter days - Vimarsana News

Editorial: With COVID vaccines, hope for brighter days

Editorial: With COVID vaccines, hope for brighter days Express-News Editorial Board FacebookTwitterEmail A woman in Florida receives a Pfizer COVID-19 vaccine. The development of vaccines in less than a year is a remarkable feat, worthy of tears and celebration.Marta Lavandier /Associated Press On April 12, 1955, the announcement from the University of Michigan that Dr. Jonas Salk’s polio vaccine was successful set off a nationwide celebration. In his Pulitzer Prize-winning book, “Polio: An American Story,” David Oshinsky describes the reaction: “Church bells tolled, factory whistles ...

Without Resources, Vaccine Rollout Could 'Fall At The Last Hurdle,' Journalist Warns - Vimarsana News

Without Resources, Vaccine Rollout Could 'Fall At The Last Hurdle,' Journalist Warns

Originally published on December 17, 2020 2:09 pm The fight against COVID-19 entered a new phase this week as American health care workers started getting vaccinated — the first in what will be a massive effort. Science writer Ed Yong of The Atlantic says the coming months will usher in the most complicated immunization program the U.S. has ever attempted. "It's going to be a slow process, and there are a lot of possible roadblocks in the way in terms of producing the vaccine, distributing it, allocating it," Yong says. "Don't think of the vaccine as a light switch — that the minute it ...

Source: wkar.org
Writer: Without Resources, COVID-19 Vaccine Rollout Could Fall At 'Last Hurdle' : Shots - Vimarsana News

Writer: Without Resources, COVID-19 Vaccine Rollout Could Fall At 'Last Hurdle' : Shots

This is FRESH AIR. I'm Terry Gross. It's astonishing that scientists were able to develop vaccines for a virus that wasn't even identified a year ago. This week, American health care workers started getting the first COVID vaccine to be approved in the U.S. Also this week, the FDA approved a new rapid test that you can take at home and get results in about 20 minutes. My guest, Ed Yong, has a new article in The Atlantic about the science that led to developing COVID vaccines in record time, the flawed science that helped lead to misguided policies and the lessons that can be applied to futur...

Source: npr.org
Vaccine D-Day Hits With 2.9 Million Doses Set for Delivery - Vimarsana News

Vaccine D-Day Hits With 2.9 Million Doses Set for Delivery

Vaccine D-Day Begins With Rollout of First 2.9 Million Doses Bloomberg 12/13/2020 Robert Langreth, John Tozzi and Angelica LaVito © Bloomberg General Gustave Perna, chief operating officer for the Defense Department's Project Warp Speed, speaks during an Operation Warp Speed vaccine summit at the White House in Washington, D.C., U.S., on Tuesday, Dec. 8, 2020. (Bloomberg) -- The first Covid-19 vaccine arrived in record time, an essential step toward ending the pandemic. Now comes the hard part: producing enough shots to immunize the majority of the U.S. population and th...

Source: msn.com